Your browser doesn't support javascript.
loading
Design, synthesis and evaluation of novel monoamine oxidase B (MAO-B) inhibitors with improved pharmacokinetic properties for Parkinson's disease.
Yi, Chao; Liu, Xinchang; Chen, Kangzhi; Liang, Haiping; Jin, Chuanfei.
  • Yi C; HEC Pharm Group, HEC Research and Development Center, Dongguan, 523871, People's Republic of China.
  • Liu X; HEC Pharm Group, HEC Research and Development Center, Dongguan, 523871, People's Republic of China; Key Lab of Functional Molecular Engineering of Guangdong Province, School of Chemistry and Chemical Engineering, South China University of Technology, Wushan Rd-381, Guangzhou 510641, People's Republi
  • Chen K; HEC Pharm Group, HEC Research and Development Center, Dongguan, 523871, People's Republic of China.
  • Liang H; HEC Pharm Group, HEC Research and Development Center, Dongguan, 523871, People's Republic of China.
  • Jin C; HEC Pharm Group, HEC Research and Development Center, Dongguan, 523871, People's Republic of China; Sunshine Lake Pharma Co. Ltd., Shenzhen, 518000, People's Republic of China. Electronic address: chuanfeijin@163.com.
Eur J Med Chem ; 252: 115308, 2023 Apr 05.
Article en En | MEDLINE | ID: mdl-37001389
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Benzofuranos Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Benzofuranos Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article